A Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight

Recruiting

Phase 3

OrforglipronA Study of Orforglipron in Female Participants With Stress Urinary Incontinence Who Have Obesity or Overweight

Sponsor:

Eli Lilly and Company

Code:

NCT07202884

Conditions

Urinary Incontinence,Stress

Eligibility Criteria

Sex: Female

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Orforglipron

Placebo

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-07-15. This information was provided to ClinicalTrials.gov by Eli Lilly and Company on 2026-06-23.